A four-gene prognostic signature for predicting the overall survival of patients with lung adenocarcinoma.

6 ), the high-risk group had a shorter survival time than the low-risk group in almost every subgroup (Stage I, p = 0.003; Stage II, p = 0.007; Stage III, p = 0.047), although the p -value did not reach statistical significance in patients younger than 65 years ( p = 0.058).

also in 111,027 other papers